Filters close
Released: 6-Feb-2014 4:00 PM EST
NIH Study Finds Regular Aspirin Use May Reduce Ovarian Cancer Risk
National Cancer Institute (NCI) at NIH

Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical recommendations can be made.

Released: 5-Feb-2014 8:50 AM EST
Adding Chemotherapy Following Radiation Treatment Improves Survival for Adults with a Slow-Growing Type of Brain Tumor
National Cancer Institute (NCI) at NIH

Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.

Released: 30-Jan-2014 2:00 PM EST
NCI Launches Trial to Assess the Utility of Genetic Sequencing to Improve Patient Outcomes
National Cancer Institute (NCI) at NIH

A pilot trial to assess whether assigning treatment based on specific gene mutations can provide benefit to patients with metastatic solid tumors is being launched this month by the National Cancer Institute (NCI), part of the National Institutes of Health.

Released: 29-Jan-2014 2:00 PM EST
TCGA Bladder Cancer Study Reveals Potential Drug Targets, Similarities to Several Cancers
National Cancer Institute (NCI) at NIH

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease.

Released: 24-Jan-2014 10:30 AM EST
NIH Scientists Map Genetic Changes That Drive Tumors in a Common Pediatric Soft-Tissue Cancer
National Cancer Institute (NCI) at NIH

Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes.

Released: 16-Dec-2013 10:45 AM EST
Lung Cancer Death Rates Continue to Fall, Helping Drive Ongoing Decrease in Overall Cancer Death Rates
National Cancer Institute (NCI) at NIH

The Annual Report to the Nation on the Status of Cancer, covering the period 1975–2010, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years.

Released: 11-Dec-2013 3:00 PM EST
NIH-Funded Study Shows Increased Survival in Men with Metastatic Prostate Cancer Who Receive Chemotherapy When Starting Hormone Therapy
National Cancer Institute (NCI) at NIH

Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.

Released: 11-Dec-2013 3:00 PM EST
New Studies Demonstrate That Modified T Cells Are Effective in Treating Blood-Borne Cancers
National Cancer Institute (NCI) at NIH

At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., investigator in the Experimental Transplantation and Immunology Branch, NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.

Released: 21-Nov-2013 2:00 PM EST
NIH Mouse Study Finds Gut Microorganisms May Determine Cancer Treatment Outcome
National Cancer Institute (NCI) at NIH

An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI).

Released: 21-Nov-2013 11:00 AM EST
Worldwide Trends Show Oropharyngeal Cancer Rates Increasing
National Cancer Institute (NCI) at NIH

NCI scientists report that the incidence of oropharyngeal cancer significantly increased during the period 1983-2002 among people in countries that are economically developed.

Released: 5-Nov-2013 3:00 PM EST
Duke Cancer Institute
NCI-Designated Cancer Centers

Among the research institutions the National Cancer Institute funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. This profile provides some history of the Duke Cancer Institute as well as a look at its current initiatives.

Released: 4-Nov-2013 11:00 AM EST
Fewer Doses of HPV Vaccine Result in Immune Response Similar to Three-Dose Regimen
National Cancer Institute (NCI) at NIH

NCI scientists report that two doses of a human papillomavirus (HPV) vaccine, trademarked as Cervarix, resulted in similar serum antibody levels against two of the most carcinogenic types of HPV (16 and 18), compared to a standard three dose regimen.

Released: 20-Sep-2013 11:00 AM EDT
Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Inventions
National Cancer Institute (NCI) at NIH

A world-wide competition to bring emerging breast cancer technologies to market is being launched by the Avon Foundation for Women, in partnership with the National Cancer Institute (NCI), part of the NIH, and the Center for Advancing Innovation.

Released: 17-Sep-2013 2:00 PM EDT
UAB Cancer Center Celebrates Grand Opening of Modernized Facility
NCI-Designated Cancer Centers

On Friday, Aug. 23, the University of Alabama at Birmingham Comprehensive Cancer Center celebrated the public grand opening of the renovated Lurleen B. Wallace Tumor Institute (WTI).

Released: 10-Sep-2013 12:00 PM EDT
UC Davis Patient Embraces Personalized Approach to Lung Cancer Diagnosis
NCI-Designated Cancer Centers

As a woman in her mid-forties who didn’t smoke, Elizabeth Lacasia never expected to be diagnosed with lung cancer. But in 2006, after she developed a persistent and serious cough, a chest X-ray and CT scan revealed several tumors in her lower left lung.

Released: 5-Sep-2013 2:00 PM EDT
NCI Clinician-Scientists at the Forefront of New Prostate Cancer Diagnostics and Treatment
National Cancer Institute (NCI) at NIH

Introduction of the UroNav was the result of nearly a decade’s research and development, principally conducted at NCI. Resembling a stylized computer workstation on wheels, the system electronically fuses together pictures from magnetic resonance imaging and ultrasound to create a detailed, three-dimensional view of the prostate, which physicians can then use to guide precision biopsies.

Released: 4-Sep-2013 4:05 PM EDT
Wear Your Vegetables
NCI-Designated Cancer Centers

With skin cancer emerging as one of the world’s most prevalent forms of cancer, researchers are using every tool at their disposal to fight this disease. The tool of choice for Sally Dickinson, PhD? Broccoli.

Released: 27-Aug-2013 11:00 AM EDT
NIH Study Links Hodgkin Lymphoma Treatment to Possible Risk of Stomach Cancer
National Cancer Institute (NCI) at NIH

Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health.

Released: 20-Aug-2013 10:00 AM EDT
Dana-Farber/ Harvard Cancer Center
NCI-Designated Cancer Centers

Among the research institutions the National Cancer Institute funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. This profile provides some history of the Dana-Farber/Harvard Cancer Center as well as a look at its current initiatives.

Released: 20-Aug-2013 10:00 AM EDT
UCCCC Researchers Pinpoint Tumor Suppressor Gene Involved in Acute Myeloid Leukemia
NCI-Designated Cancer Centers

Researchers at the University of Chicago Medicine Comprehensive Cancer Center (UCCCC) have identified a gene that contributes to the development of acute myeloid leukemia (AML). This pivotal finding follows 40 years of University of Chicago research that has slowly unraveled the genetic basis of leukemia.



close
0.13235